Search

Your search keyword '"Campori E"' showing total 89 results
Start Over Author "Campori E"
89 results on '"Campori E"'

2. Treatment: rapid improvement in information processing after sleep deprivation and sleep-phase advance in bipolar depression

Author

Benedetti F, Barbini B, Florita M, Cigala Fulgosi M, Pontiggia A, Campori E, Colombo C, Smeraldi E, Benedetti, F, Barbini, B, Florita, M, Cigala Fulgosi, M, Pontiggia, A, Campori, E, Colombo, C, and Smeraldi, E

Subjects
Sleep deprivation Sleep phase-advance Cingulate cortex Signal detection Self-schema
Abstract

Object: Sleep phase advance can prevent and substain the antidepressant effect of total sleep deprivation. Weevaluate the neuropsychological assessment during this cronotherapeutic procedureMethod: We tested self-description and recognition memory in 23 bipolar depressed inpatients treated with totalsleep deprivation followed by sleep phase-advance.Results: Treatment reverted and normalized the baseline biases toward negative stimuli.Conclusions: Changes in neuropsychological performance paralleled changes of mood, and could be explainedby treatment effects on anterior cingulate cortex metabolism

Published
2005

9. Deprivazione di sonno e disturbo bipolare

Author

Benedetti F, Barbini B, Campori E, Cigala Fulgosi M, Smeraldi E., COLOMBO , CRISTINA ANNA, Benedetti, F, Barbini, B, Campori, E, Cigala Fulgosi, M, Colombo, CRISTINA ANNA, and Smeraldi, E.

Published
2001

11. Strategie di potenziamento non farmacologico

Author

Benedetti F, Barbini B, Campori E, Cigala Fulgosi M, Smeraldi E., COLOMBO , CRISTINA ANNA, Benedetti, F, Barbini, B, Campori, E, Cigala Fulgosi, M, Colombo, CRISTINA ANNA, and Smeraldi, E.

Published
2001

12. Ritmi, sonno e disturbo bipolare

Author

Benedetti F, Barbini B, Campori E, Cigala Fulgosi M, Colombo C, Smeraldi E, Benedetti, F, Barbini, B, Campori, E, Cigala Fulgosi, M, Colombo, C, and Smeraldi, E

Published
2001

13. Sole, luce e terapia dei disturbi dell’umore

Author

Benedetti F, Barbini B, Campori E, Cigala Fulgosi M, Smeraldi E., COLOMBO , CRISTINA ANNA, Benedetti, F, Barbini, B, Campori, E, Cigala Fulgosi, M, Colombo, CRISTINA ANNA, and Smeraldi, E.

Published
2001

22. Effect of sleep deprivation combined with dopamine agonist amineptine in bipolar depression

Author

Campori E, Benedetti F, Barbini B, Smeraldi E. Effect of sleep deprivation combined with dopamine agonist amineptine in bipolar d.e.p.r.e.s.s.i.o.n. 21st CINP Congress, 1998 Jul 12 16, G.l.a.s.g.o.w. Book of abstracts, p. 268, COLOMBO , CRISTINA ANNA, Campori, E, Benedetti, F, Barbini, B, Colombo, CRISTINA ANNA, 21st CINP Congress, Smeraldi E. Effect of sleep deprivation combined with dopamine agonist amineptine in bipolar d. e. p. r. e. s. s. i. o. n., 1998 Jul 12, 16, Book of abstracts, G. l. a. s. g. o. w., and P., 268

Published
1998

29. Perceived symptomatology and biological rhythms in unipolar patiens. World Conference on Chronobiology and Chronotherapeutics. Biological Rhythms Research; 26:365

Author

Barbini B, Benedetti F, Campori E, Guglielmo E, Smeraldi E. Perceived symptomatology, biological rhythms in unipolar p.a.t.i.e.n.s. World Conference on Chronobiology, C.h.r.o.n.o.t.h.e.r.a.p.e.u.t.i.c.s. Biological Rhythms Research, 26:365, COLOMBO , CRISTINA ANNA, Barbini, B, Benedetti, F, Campori, E, Guglielmo, E, Colombo, CRISTINA ANNA, Smeraldi E., Perceived symptomatology, World Conference on Chronobiology, biological rhythms in unipolar p. a. t. i. e. n. s., Biological Rhythms Research, C. h. r. o. n. o. t. h. e. r. a. p. e. u. t. i. c. s., and 26:365

Published
1995

45. Dopaminergic augmentation of sleep deprivation effects in bipolar depression

Author

Francesco Benedetti, Barbara Barbini, Mara Cigala Fulgosi, Euridice Campori, Cristina Colombo, Benedetti, F, Campori, E, Barbini, B, Fulgosi, Mc, and Colombo, C

Subjects
Male, endocrine system, medicine.medical_specialty, Bipolar Disorder, Lithium (medication), Amineptine, Dibenzocycloheptenes, Placebo, Internal medicine, medicine, Humans, Bipolar disorder, Psychiatry, Biological Psychiatry, Dopaminergic, Middle Aged, medicine.disease, Psychiatry and Mental health, Sleep deprivation, Endocrinology, Mood, Dopamine Agonists, Sleep Deprivation, Antidepressant, Female, medicine.symptom, Psychology, Follow-Up Studies, medicine.drug
Abstract

Total sleep deprivation (TSD) has been used in association with lithium salts and with serotonergic and noradrenergic antidepressants, leading to sustained improvements in patients affected by major depression. Current theories on the neurobiological mechanism of action of TSD propose a major role for enhanced dopamine activity, To test the clinical relevance of dopaminergic enhancement in TSD, we treated a homogeneous sample of 28 bipolar depressed patients with three cycles of TSD combined with placebo or with the dopaminergic antidepressant amineptine. Changes in mood over time were rated with self-administered visual analogue scales and with the Montgomery-Asberg Depression Rating Scale. Patients showed improved mean daily-mood scores after TSD, an effect that was highest at the first cycle and decreased with treatment repetition. Amineptine enhanced the effects of TSD on perceived mood during the first two TSD cycles, but patients in the placebo and amineptine groups showed comparable results at the end of the treatment. Despite its theoretical importance, the clinical usefulness of combining TSD with a dopaminergic agent must be questioned. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

Published
2001
Full Text
View/download PDF

46. Ongoing Lithium Treatment Prevents Relapse After Total Sleep Deprivation

Author

Euridice Campori, Francesco Benedetti, Enrico Smeraldi, Cristina Colombo, Barbara Barbini, Benedetti, F, Colombo, C, Barbini, B, Campori, E, and Smeraldi, E

Subjects
Male, endocrine system, Bipolar Disorder, Lithium (medication), Visual analogue scale, Lithium, Serotonergic, chemistry.chemical_compound, Secondary Prevention, medicine, Humans, Pharmacology (medical), Bipolar disorder, Lithium carbonate, Hamilton Rating Scale for Depression, Middle Aged, medicine.disease, Privation, Psychiatry and Mental health, Mood, chemistry, Anesthesia, Sleep Deprivation, Female, Psychology, medicine.drug
Abstract

Forty bipolar depressed inpatients underwent three consecutive cycles of total sleep deprivation (TSD). At the beginning of the study, 20 patients were free of psychotropic drugs and 20 had been receiving Lithium medication for at least 6 months. Mood was rated on the Hamilton Rating Scale for Depression before and after TSD; perceived mood changes during treatment were evaluated with self-administered visual analog scales. Patients undergoing long-term lithium treatment showed a significantly better response to TSD as rated on both scales: 13 of 30 patients (rs. 2 of 20 patients without Lithium) showed a sustained response during a follow-up period of 3 months. This preliminary evidence of a positive interaction of TSD and long-term Lithium treatment could be explained by a synergistic effect of both treatments on brain serotonergic function, possibly via a desensitization of 5-hydroxytryptamine-1A inhibitory autoreceptors.

Published
1999
Full Text
View/download PDF

47. Sustained Antidepressant Effect of Sleep Deprivation Combined with Pindolol in Bipolar Depression A Placebo-Controlled Trial

Author

Euridice Campori, Barbara Barbini, Francesco Benedetti, Cristina Colombo, Enrico Smeraldi, Smeraldi, E., Benedetti, F., Barbini, B., Campori, E., and Colombo, C.

Subjects
Adult, Male, endocrine system, Bipolar Disorder, Lithium (medication), Adrenergic beta-Antagonists, Placebo-controlled study, Placebo, Serotonergic, medicine, Humans, Bipolar disorder, Pindolol, Psychiatric Status Rating Scales, Pharmacology, Depressive Disorder, Middle Aged, medicine.disease, Combined Modality Therapy, Affect, Psychiatry and Mental health, Sleep deprivation, Anesthesia, Acute Disease, Sleep Deprivation, Antidepressant, Female, medicine.symptom, Psychology, medicine.drug
Abstract

Total sleep deprivation (TSD) shows powerful but transient clinical effects in patients affected by bipolar depression. Pindolol blocks the serotonergic 5-HT1A autoreceptor, thus improving the antidepressant effect of selective serotonin reuptake inhibitors. We evaluated the interaction of TSD and pindolol in the treatment of acute episodes of bipolar depression. Forty bipolar depressed inpatients were randomized to receive pindolol 7.5 mg/day or placebo for nine days in combination with three consecutive TSD cycles. Pindolol significantly improved the antidepressant effect of TSD, and prevented the short-term relapse after treatment. The response rate (HDRS scores

Published
1999
Full Text
View/download PDF

48. Lithium Overcomes the Influence of 5-HTTLPR Gene Polymorphism on Antidepressant Response to Sleep Deprivation

Author

Francesco Benedetti, Euridice Campori, Alessandro Bernasconi, Enrico Smeraldi, Adriana Pontiggia, Cristina Colombo, Cristina Lorenzi, Mara Cigala Fulgosi, Sara Dallaspezia, Barbara Barbini, Daniele Radaelli, Benedetti, F, Barbini, B, Bernasconi, A, Fulgosi, Mc, Campori, E, Colombo, C, Dallaspezia, S, Lorenzi, C, Pontiggia, A, Radaelli, D, and Smeraldi, E

Subjects
Psychiatry and Mental health, Sleep deprivation, Lithium (medication), business.industry, 5-HTTLPR, Medicine, Antidepressant, Pharmacology (medical), Gene polymorphism, medicine.symptom, business, Bioinformatics, medicine.drug
Published
2008
Full Text
View/download PDF

49. The unipolar–bipolar dichotomy and the response to sleep deprivation

Author

Cristina Colombo, Laura Bellodi, Barbara Barbini, Enrico Smeraldi, Francesco Benedetti, Euridice Campori, Barbini, B, Colombo, C, Benedetti, F, Campori, E, Bellodi, L, and Smeraldi, E

Subjects
Adult, Male, endocrine system, medicine.medical_specialty, Bipolar Disorder, Time Factors, Diagnosis, Differential, Rating scale, mental disorders, medicine, Humans, Bipolar disorder, Psychiatry, Major depressive episode, Biological Psychiatry, Depression (differential diagnoses), Analysis of Variance, Depressive Disorder, Chi-Square Distribution, Depression, Discriminant Analysis, Middle Aged, medicine.disease, Psychiatry and Mental health, Sleep deprivation, Treatment Outcome, Mood, Disease Progression, Sleep Deprivation, Major depressive disorder, Female, medicine.symptom, Psychology, Mania
Abstract

Fifty-one inpatients affected by a major depressive episode were divided into four groups according to mood disorder diagnosis and previous clinical history (bipolar disorder type I; bipolar disorder type II; major depressive disorder with at least three previous depressive episodes; and single depressive episode patients) and administered three consecutive total sleep deprivation (TSD) cycles. Mood changes were rated with a reduced version of the Hamilton Depression Rating Scale and with self-administered visual analogue scales. TSD caused better clinical effects in bipolar and single-episode patients; in particular, unipolar patients lacked effects in perceived mood after the first TSD and showed worse Hamilton ratings in respect to the other groups after the three TSD treatments. Discriminant function analysis could correctly classify 80% of bipolar patients, post hoc, based on TSD response. Further researches on the clinical efficacy of TSD must take into account the heterogeneity of depression and of its biological substrate. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.

Published
1998
Full Text
View/download PDF

50. Fluvoxamine Treatment of Major Depression Associated With Multiple Sclerosis

Author

Francesco Benedetti, Cristina Colombo, Euridice Campori, Enrico Smeraldi, Benedetti, Francesco, Campori, E, Colombo, CRISTINA ANNA, and Smeraldi, E.

Subjects
Adult, Male, medicine.medical_specialty, Multiple Sclerosis, Fluvoxamine, Severity of Illness Index, Drug Administration Schedule, Central nervous system disease, Adjuvants, Immunologic, Internal medicine, Severity of illness, medicine, Humans, Depression (differential diagnoses), Depressive Disorder, Major, Multiple sclerosis, Interferon beta-1b, Interferon-beta, Middle Aged, medicine.disease, Psychiatry and Mental health, Treatment Outcome, Endocrinology, Female, Neurology (clinical), Mental Status Schedule, Psychology, Reuptake inhibitor, Selective Serotonin Reuptake Inhibitors, Follow-Up Studies, medicine.drug, Psychopathology
Abstract

Fluvoxamine 200 mg was administered for 3 months to a group of 43 interferon beta-1b treated patients affected by major depression associated with multiple sclerosis. Despite a 16.3% attrition rate, 79% of patients achieved response. The drug was well tolerated. Fluvoxamine 200 mg was administered for 3 months to a group of 43 interferon beta-1b treated patients affected by major depression associated with multiple sclerosis. Despite a 16.3% attrition rate, 79% of patients achieved response. The drug was well tolerated.

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results